Latest draft of Unified Patent Court rules released

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Latest draft of Unified Patent Court rules released

The group of patent judges and practitioners in charge of drawing up the rules of procedure for the Unified Patent Court has published its latest draft, together with a summary of the changes and the rationale for them

The Expert Group, chaired by Kevin Mooney, says that the 16th draft reflects the responses the group received to the latest round of consultations, which closed in October.

The Group has also published a summary of the changes it has proposed, explaining why its members rejected or accepted recommendations for each change.

The Legal Group of the Preparatory Committee, chaired by Germany’s Johannes Karcher, will now consider the draft set of rules at the level of participating EU member states. It plans to hold a hearing later this year on the suggested amendments to the text. The hearing is expected to be in September or October.

The publication of the latest draft comes a week after a group of technology companies wrote an open letter calling for additional “judicial guidance” on bifurcation and injunctions.

The 19 signatory companies and associations, many of whom operate in the electronics and computing sectors, are particularly concerned that troll-like patent owners could abuse the new UPC to block the sale of products based on dubious patents.

On this issue, the Expert Group notes that Intel claimed that Rule 211 of the earlier draft “provides too little guidance on how to exercise discretion to grant provisional relief” and is “concerned that different local and/or regional courts will adopt divergent approaches”.

In response, the Group says it has agreed to reword Rule 211.3 to incorporate text based on Article 62(2) to state “…the Court shall in the exercise of its discretion weigh up the interests of the parties and, in particular, take into account the potential harm for either of the parties resulting from the granting or the refusal of the injunction.”

The Group says it has also agreed that the Court should have regard to unreasonable delay when it comes to granting injunctions.

You can read more about the next steps for setting up the UPC, including the appointment of judges, here.

more from across site and SHARED ros bottom lb

More from across our site

The departure of a large chunk of Spruson & Ferguson's legacy leadership could have destabilised the firm, but its fighting back with strategic hires and promotions
By accepting a relatively small sample of infringing content to grant worldwide relief, a UK court has adopted a pragmatic approach that could reduce the time and expense involved in huge enforcement actions
This year’s IP STARS Americas rankings reveal that firms are expanding their capabilities, particularly in trade secrets and life sciences
Law firms’ expanding IP capabilities are driving broader industry recognition across a wider range of practice areas
As specialist boutiques challenge traditional firm models, major disputes involving Disney, Ericsson, Siemens and Dolby highlight the firms winning work before the UPC
The firm has added two leading damages specialists as it expands beyond technical analysis and deepens its role in the economics of IP litigation
Josh Seidenfeld, partner at DLA Piper, outlines the emerging legal trends that drive the future of life sciences innovation and how stakeholders can prepare for the future
South Korea's One Law Partners is combining with boutique firm Minwho Law Group to leverage global expansion of K-content and build a broader offering spanning IP, tech and regulatory advisory work
Russell Kennedy's Gina Tresidder on juggling matters, delivering hard truths, and why IP ownership is rarely as simple as people think
Attorney Oran Friar and trainee attorney Harry Cunliffe at Reddie & Grose, share that patent filings for clinical LLMs are surging, but success in the UK and Europe hinges on demonstrating technical innovation
Gift this article